← Open Payments lookup

TASHI CHONEY: Open Payments

NPI 1922304013 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$837 in 27 payments from 9 companies in 2025. Trend: 2023 $395 · 2024 $311 · 2025 $837

Food & beverage: $837
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$271
Gilead Sciences, Inc.8$192
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$183
Mirum Pharmaceuticals, Inc.2$72
Ipsen Biopharmaceuticals, Inc1$33
Medtronic, Inc.1$28
ORPHALAN INC1$27
Takeda Pharmaceuticals U.S.A., Inc.1$17
Lilly USA, LLC1$15

Products named: REZDIFFRA, XIFAXAN, Livmarli, IQIRVO, INCEPTIV, CUVRIOR, LIVTENCITY, OMVOH.

Industry payments across NY — which companies pay providers there.